Normal liver cells could restrict the tumor growth. This discovery identifies a strategy to fight against liver cancer and inspires new therapeutic approaches that mobilize normal cells to kill cancer cells.
Normal liver cells surrounding a tumor activates a defence mechanism that resticts tumor growth, according to a study conducted at the VIB-KU Leuven Center for Cancer Biology. Researchers also found that hyperactivation of this mechanism enhanced the elimination of different types of liver tumors in mice. The results of the study are published in Science.// Fighting tumors
Current chemotherapies aim at killing rapidly proliferating cancer cells. However, such therapies are often only temporarily effective because cancer cells quickly evolve drug resistance. Nowadays, other approaches such as immune therapy do not target tumor cells themselves but activate the natural defense function of the immune system.
‘Activation of genes YAP and TAZ around tumors in the liver provides anti-tumor effect. This discovery holds promise to provide ground-breaking insights into a new strategy to fight cancer.’
Read More..
The study, led by Prof. Georg Halder (VIB-KU Leuven Center for Cancer Biology), showed that not only the immune system but also non-cancerous liver cells around liver tumors have the capacity to kill nearby tumor cells. When they experimentally activated this novel mechanism in mice with liver tumors, these mice survived significantly longer and had a drastically reduced tumor burden. Read More..
Prof. Halder says: "While the study shows that this anti-tumor mechanism exists, how exactly activated liver cells cause the elimination of cancer cells is not known, but it is obviously a highly significant question that we are currently investigating."
Unexpected genes
By studying tumor tissues from cancer patients and mouse models for liver cancer, the scientists found that the genes YAP and TAZ were activated around tumors in the liver and that this was the driving force of the anti-tumor mechanism.
This observation was surprising because YAP and TAZ are usually highly expressed in different human cancers where they drive tumor cell proliferation and survival.
Advertisement
Towards new therapies
Advertisement
"Given the striking anti?tumor effect of YAP?activated liver cells on liver tumors, our discovery has the potential to provide ground-breaking insights into a novel strategy to fight," says Stephanie Castaldo, co-first-author.
However, while this remarkable finding identifies a completely new strategy to fight cancer in mice, this study is the first molecular characterization of this novel anti-tumor mechanism which means that more research is needed to investigate how these findings can be applied to benefit cancer patients. "Indeed, the next step is to test to what degree this mechanism also affects human cancer cells," says Laura Van den Mooter, also co-first-author.
Source-Eurekalert